Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Every year in France, from 100 000 to 145 000 people are affected by a stroke. 75% patients survived with aftereffects, in particular aphasic disorders.
A sketch of a new tool called BESTA aiming to a rapid handover to the acute phase post stroke had been worked out. After a meeting, 13 multidisciplinary experts have discussed, adjusted and a new complete tool (BESTA) had been created in order to evaluate the different states of aphasia.
The goal of this study is the validation and the standardization of this new BESTA tool.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BESTA scale | BESTA scale is administered at T0, T1 (3 months) and T2 (1 year) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BESTA scale | Other | BESTA scale is administrated at T0, T1 and T2. |
|
| Measure | Description | Time Frame |
|---|---|---|
| validity of concomitant criterion at T0 versus LAST | T0: the gold standard was determined by the expert group is the LAST screening tool. The tool to be evaluated is the BESTA at T0. However, as written expression is not evaluated in the LAST, only the dimensions and Oral Expression Listening Comprehension of BESTA may actually be faced with LAST scale. | 1 day |
Not provided
Not provided
Inclusion Criteria:
Patients with stroke:
Healthy Volunteers:
Exclusion Criteria:
Patients with stroke and Healthy Volunteers :
Not provided
Not provided
Not provided
Administration of BESTA scale (test to assess) within 3 days after stroke and at 3 months and 1 year after stroke. This scale will be compared to standard scales.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Francisco MACIAN, MD | University Hospital, Limoges | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Limoges Hospital | Limoges | 87 042 | France |
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided